HOME New on the Site Customer Service Sample Newsletters MarketPlace
AIS Products & Services

Free E-Mail Newsletters

Health Business Daily

Government News

Sign Up for Free E-Mail Newsletters

Health Business Job Openings

Health Business Meetings

People on the Move

Health Plans

General Business Issues

Product News

Company Intelligence

Disease Management

Blue Cross and Blue Shield

Medicare Advantage

Managed Medicaid

Health Plan Products

Compliance

Compliance Strategies

HIPAA Resource Center

Government Resources

Compliance Products

Pharmacy Benefit

Pharmacy Benefit Mgmt.

Specialty Pharmacy

Drug Mgmt. Products

Consumer-Directed Care

Articles on CDH

CDH Data

CDH Products

Market Data

Health Plan Enrollment

Pharmacy Benefit Mgmt.

Data Products

Health Reform

Obama Administration

Federal Legislation

State Legislation

State Results

Association Positions

Research Organizations

MarketPlace

Newsletters

Web Services & Looseleaf Guides

Books & Reports, Directories & Databases

Live Meetings & Audioconferences

Alphabetical Listing

Health Care Career Center

Health Care Links

Press Release Library

Visit AISEducation.com for more news and strategic information for today's business leaders

Articles on Pharmacy Benefit Management

Stories are listed in chronological order,
with the most recent appearing first.

Articles on Specialty Pharmacy

Personalized Medicine Is Growing, but Health Plans Need Policies for Coverage

New Privacy Rules in Economic Stimulus Law Will Restrict Certain Pharmaceutical Marketing Practices

PBMs Tout Their Transparency, but Model Doesn't Always Lower Drug Costs for Clients

Health Insurers See Value of Covering Members in Rx Clinical Trials

Rx Issues Will Fit in Health Care Reform Mix, but May Wait Behind Other Priorities

Caterpillar/Wal-Mart Rx Drug Pilot Scraps Use of Average Wholesale Price, Uses Drug Cost-Plus Pricing

Health Insurers Roll Out Value-Based Prescription Drug Plans, Tap a Growing Demand

Oral Rx Drugs for Asthma Generate Better Compliance Than Inhalers

Biotech, Pharma Firms Eye New Payment Models Based on Value

Wal-Mart's Expanded Generic Rx Plan Is Not Seen as a Threat to PBMs

PBMs Allegedly Manipulate Definition of 'Brand' and 'Generic' Rx at Payers' Expense

Incentives for Patients to Switch From Prescription to Over-the-Counter Drugs Can Produce Large Savings for Members and Plans Alike

As Prescription Drug Costs Rise, Some Health Plans and PBMs Are Putting a Higher Priority on Improving Interactions With Physicians

Generic Rx Copays Are Steady or Dropping, With Wal-Mart's $4 Generics Seen as a Factor

PBMs, Health Plans Are Working with States to Stem the Alarming Increase in Abuse of Prescription Drugs

'Value-Based' Prescription Drug Programs Gain Traction With Several Large Health Plans

Proposed 'Behind-the-Counter' Category of Drugs Would Give Health Plans and PBMs New Cost-Saving Opportunities

Six Therapeutic Drug Categories That Could See Important New Drugs Emerge From the Pipeline in 2008

Aetna's E-Prescribing Pilot Causes Increases in Generic Drug Prescriptions and Formulary Compliance

New Law Now Gives FDA Sweeping New Authority over the Safety of Marketed Prescription Drugs

Future Alzheimer's Treatments May Echo the Model Used for Cholesterol

Plans, PBMs Push Pill Splitting, but New Generics Lessen Impact

Part D Sponsors Scramble to Make Changes on 2008 Formularies

Tenn. Blues: 'Rx Repository, e-Prescribing May Curb Drug Use'

Compliance With Ulcerative Colitis Therapy Can Cut Costs, Improve Outcomes

More PBM Transparency May Not Cut Costs, but Could Boost Trust

PBM Mail Order Rx Services Are Expanding, But the Cost Savings Are Not Clear

Generic Rx Programs Proliferate in Wake of Wal-Mart's Initiative

E-Prescribing Holds Promise for Improving Rx Drug Adherence

Commercial Payers Are Starting to Use Medicare's Average Sales Price`

Polypharmacy Control Is Key for Psych Rx Savings Under Part D

Why the Plans of a Major Drug Purchasing Coalition Did Not Work

Experts Offer Advice to Payers on Comparing Transparent PBM Bids

Premera Sees 'Transparency' as Being More Than Rebates, Discounts

'PBA' Model Is Defined by Full Disclosure, Low Net Cost, High Degree of Client Control

Hot Products

• Specialty Pharmacy: Stakeholders, Strategies and Markets 2009

• Pharmacy Benefit Trends & Data: 2000-2007 Survey Results

• The Next Generation of Disease Management: 2009 and Beyond

• Drug Benefit News

• Managing Cancer Care: Improve Outcomes and Lower Costs

See full listing
of products at
AIS Marketplace

Contact AIS

About AIS

Advertise With AIS

Privacy

Site Map